Votas 0.3 Tablet DT
Marketer
Tas Med India Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Votas 0.3 Tablet DT
Diabetac 0.3mg tablets are prescribed for managing type 2 diabetes. They help regulate post-prandial hyperglycemia (high blood sugar after meals). This medication is indicated when dietary modifications and other antidiabetic agents prove insufficient in controlling elevated blood glucose. Diabetac 0.3mg tablets should be administered immediately prior to meals. Dosage and frequency are determined by your physician to optimize glycemic control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, potentially resulting in serious complications such as nephropathy or vision impairment. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include abdominal discomfort, bloating, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your doctor. While unlikely to induce hypoglycemia independently, concomitant use with other antidiabetic therapies (particularly insulin or sulfonylureas) may increase this risk. Glucose, not sucrose, should be used to treat hypoglycemic episodes. Inform your doctor about any pre-existing hepatic or renal conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice before use. To ensure medication safety, disclose all other medications currently in use. Excessive alcohol consumption should be avoided due to the increased risk of hypoglycemia.
Uses of Votas 0.3 Tablet DT
Managing type 2 diabetes
Major Benefits of Votas 0.3 Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve one tablet in water before consumption. Administer Votas 0.3 Tablet DT on an empty stomach.
Common Side effects of Votas 0.3 Tablet DT:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Votas 0.3 Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Dissolve the tablet in water before consumption. Administer Votas 0.3 Tablet DT on an empty stomach.
How Votas 0.3 Tablet DT works:
Diabetics may benefit from Votas 0.3 DT tablets, which function by blocking the digestive enzymes that convert complex carbohydrates into simple sugars like glucose. This action helps to regulate postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Votas 0.3 DT tablets.
PregnancySAFE IF PRESCRIBED
The use of Votas 0.3 Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Votas 0.3 Tablet DT appear compatible. Available human data indicates minimal risk to the nursing infant.
DrivingSAFE
Driving ability is typically unaffected by Votas 0.3 Tablet DT.
KidneyCAUTION
Patients with severe kidney impairment should use Votas 0.3 Tablet DT cautiously. Dosage modification for Votas 0.3 Tablet DT might be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Votas 0.3 Tablet DT. Dosage modification of Votas 0.3 Tablet DT may be necessary. Physician consultation is recommended.
What if you forget to take Votas 0.3 Tablet DT :
Omit any missed Votas 0.3 DT Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Votas 0.3 Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |


